메뉴 건너뛰기




Volumn 120, Issue 22, 2014, Pages 3485-3493

Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS-HCC risk model

Author keywords

cirrhosis; hepatocellular carcinoma; liver cancer; risk factors; risk model; Scientific Registry of Transplant Recipients (SRTR)

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VALIDATION STUDY;

EID: 85006513468     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28832     Document Type: Article
Times cited : (123)

References (28)
  • 1
    • 0033545541 scopus 로고    scopus 로고
    • Rising incidence of hepatocellular carcinoma in the United States
    • El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745-750.
    • (1999) N Engl J Med , vol.340 , pp. 745-750
    • El-Serag, H.B.1    Mason, A.C.2
  • 2
    • 63049133092 scopus 로고    scopus 로고
    • Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005
    • Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27:1485-1491.
    • (2009) J Clin Oncol , vol.27 , pp. 1485-1491
    • Altekruse, S.F.1    McGlynn, K.A.2    Reichman, M.E.3
  • 3
    • 84969130321 scopus 로고    scopus 로고
    • AtlantaGAAmerican Cancer Societym, American Cancer Society
    • AtlantaGAAmerican Cancer Society. Cancer Facts & Figures 2012. : American Cancer Society; 2012.
    • (2012) Cancer Facts & Figures 2012
  • 4
    • 85006484211 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention, National Center for Health Statistics, Accessed February 12
    • Centers for Disease Control and Prevention, National Center for Health Statistics. Mortality Files. cdc.gov/Nchs/. Accessed February 12, 2013.
    • (2013) Mortality Files. cdc.gov/Nchs/
  • 5
    • 7044272630 scopus 로고    scopus 로고
    • Hepatocellular carcinoma in cirrhosis: incidence and risk factors
    • Fattovich G, Stroffolini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5 suppl 1):S35-S50.
    • (2004) Gastroenterology , vol.127 , Issue.5 , pp. S35-S50
    • Fattovich, G.1    Stroffolini, T.2    Zagni, I.3
  • 6
    • 84860287080 scopus 로고    scopus 로고
    • Epidemiology of viral hepatitis and hepatocellular carcinoma
    • El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264-1273.e1.
    • (2012) Gastroenterology , vol.142 , pp. 1264-1273
    • El-Serag, H.B.1
  • 7
    • 79952231921 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma: an update
    • Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020-1022.
    • (2011) Hepatology , vol.53 , pp. 1020-1022
    • Bruix, J.1    Sherman, M.2
  • 8
    • 84858658381 scopus 로고    scopus 로고
    • EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
    • European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908-943.
    • (2012) J Hepatol , vol.56 , pp. 908-943
  • 9
    • 84984586846 scopus 로고    scopus 로고
    • Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
    • Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4:439-474.
    • (2010) Hepatol Int , vol.4 , pp. 439-474
    • Omata, M.1    Lesmana, L.A.2    Tateishi, R.3
  • 11
    • 85006486235 scopus 로고    scopus 로고
    • Fort Washington, PA, National Comprehensive Cancer Network
    • National Comprehensive Cancer Network. NCCN Guidelines Version 2.2012: Hepatocellular Carcinoma. Fort Washington, PA: National Comprehensive Cancer Network; 2012.
    • (2012) NCCN Guidelines Version 2.2012: Hepatocellular Carcinoma
  • 12
    • 79551648518 scopus 로고    scopus 로고
    • Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States
    • Davila JA, Henderson L, Kramer JR, et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med. 2011;154:85-93.
    • (2011) Ann Intern Med , vol.154 , pp. 85-93
    • Davila, J.A.1    Henderson, L.2    Kramer, J.R.3
  • 13
    • 70450240875 scopus 로고    scopus 로고
    • Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting
    • Wong CR, Garcia RT, Trinh HN, et al. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting. Dig Dis Sci. 2009;54:2712-2721.
    • (2009) Dig Dis Sci , vol.54 , pp. 2712-2721
    • Wong, C.R.1    Garcia, R.T.2    Trinh, H.N.3
  • 14
    • 33645683837 scopus 로고    scopus 로고
    • Analytical methods and database design: implications for transplant researchers, 2005
    • Levine GN, McCullough KP, Rodgers AM, et al. Analytical methods and database design: implications for transplant researchers, 2005. Am J Transplant. 2006;6(5 pt 2):1228-1242.
    • (2006) Am J Transplant , vol.6 , Issue.5 , pp. 1228-1242
    • Levine, G.N.1    McCullough, K.P.2    Rodgers, A.M.3
  • 15
    • 0033019013 scopus 로고    scopus 로고
    • Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease
    • Caldwell SH, Oelsner DH, Iezzoni JC, et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29:664-669.
    • (1999) Hepatology , vol.29 , pp. 664-669
    • Caldwell, S.H.1    Oelsner, D.H.2    Iezzoni, J.C.3
  • 16
    • 0033797838 scopus 로고    scopus 로고
    • Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study
    • Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology. 2000;32(4 pt 1):689-692.
    • (2000) Hepatology. , vol.32 , Issue.4 , pp. 689-692
    • Poonawala, A.1    Nair, S.P.2    Thuluvath, P.J.3
  • 17
    • 0015854966 scopus 로고
    • Transection of the oesophagus for bleeding oesophageal varices
    • Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-649.
    • (1973) Br J Surg , vol.60 , pp. 646-649
    • Pugh, R.N.1    Murray-Lyon, I.M.2    Dawson, J.L.3
  • 18
    • 0034728356 scopus 로고    scopus 로고
    • What do we mean by validating a prognostic model?
    • Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med. 2000;19:453-473.
    • (2000) Stat Med , vol.19 , pp. 453-473
    • Altman, D.G.1    Royston, P.2
  • 19
    • 0030069896 scopus 로고    scopus 로고
    • Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
    • Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
    • (1996) Stat Med , vol.15 , pp. 361-387
    • Harrell, F.E.1    Lee, K.L.2    Mark, D.B.3
  • 20
    • 57349116772 scopus 로고    scopus 로고
    • Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon
    • Di Bisceglie AM, Shiffman ML, Everson GT, et al. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med. 2008;359:2429-2441.
    • (2008) N Engl J Med , vol.359 , pp. 2429-2441
    • Di Bisceglie, A.M.1    Shiffman, M.L.2    Everson, G.T.3
  • 21
    • 79952316752 scopus 로고    scopus 로고
    • Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C
    • quiz e12
    • Lok AS, Everhart JE, Wright EC, et al; HALT-C Trial Group. Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. Gastroenterology. 2011;140:840-849; quiz e12.
    • (2011) Gastroenterology , vol.140 , pp. 840-849
    • Lok, A.S.1    Everhart, J.E.2    Wright, E.C.3
  • 22
    • 0033936550 scopus 로고    scopus 로고
    • Time-dependant ROC curves for censored survival data and a diagnostic marker
    • Heagerty PJ, Lumley T, Pepe MS. Time-dependant ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337-344.
    • (2000) Biometrics , vol.56 , pp. 337-344
    • Heagerty, P.J.1    Lumley, T.2    Pepe, M.S.3
  • 23
    • 56949094767 scopus 로고    scopus 로고
    • Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
    • Yuen MF, Tanaka Y, Fong DY, et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol. 2009;50:80-88.
    • (2009) J Hepatol , vol.50 , pp. 80-88
    • Yuen, M.F.1    Tanaka, Y.2    Fong, D.Y.3
  • 24
    • 59849093175 scopus 로고    scopus 로고
    • Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease
    • Lok AS, Seeff LB, Morgan TR, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009;136:138-148.
    • (2009) Gastroenterology , vol.136 , pp. 138-148
    • Lok, A.S.1    Seeff, L.B.2    Morgan, T.R.3
  • 25
    • 84984550778 scopus 로고    scopus 로고
    • Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
    • Yang HI, Yuen MF, Chan HL, et al. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet Oncol. 2011;12:568-574.
    • (2011) Lancet Oncol , vol.12 , pp. 568-574
    • Yang, H.I.1    Yuen, M.F.2    Chan, H.L.3
  • 26
    • 84863774717 scopus 로고    scopus 로고
    • Development of a prediction model for 10-year risk of hepatocellular carcinoma in middle-aged Japanese: The Japan Public Health Center-based Prospective Study Cohort II
    • Michikawa T, Inoue M, Sawada N, et al; Japan Public Health Center-based Prospective Study Group. Development of a prediction model for 10-year risk of hepatocellular carcinoma in middle-aged Japanese: The Japan Public Health Center-based Prospective Study Cohort II. Prev Med. 2012;55:137-143.
    • (2012) Prev Med , vol.55 , pp. 137-143
    • Michikawa, T.1    Inoue, M.2    Sawada, N.3
  • 27
    • 0037369657 scopus 로고    scopus 로고
    • Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
    • Velazquez RF, Rodriguez M, Navascues CA, et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology. 2003;37:520-527.
    • (2003) Hepatology , vol.37 , pp. 520-527
    • Velazquez, R.F.1    Rodriguez, M.2    Navascues, C.A.3
  • 28
    • 84855306790 scopus 로고    scopus 로고
    • Highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein: a new tool for the management of hepatocellular carcinoma
    • Toyoda H, Kumada T, Tada T. Highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein: a new tool for the management of hepatocellular carcinoma. Oncology. 2011;81(suppl 1):61-65.
    • (2011) Oncology , vol.81 , pp. 61-65
    • Toyoda, H.1    Kumada, T.2    Tada, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.